Update on re-appointment of Dr. Mukund Gurjar as a Whole-time Director of the Company and appointment of Secretarial Auditor of the Company in the 44th AGM

Read More

Intimation of dispatch of letters to Shareholders whose e-mail addresses are not registered with the Company/Depository Participants

Read More

Audio recording of Earnings call – Q1 FY 26

Read More

Outcome of Board Meeting & Financial Results Q1 FY26

Read More

Appointment of Senior Management Personnel – Mr. R. S. Vasan

Read More

US FDA inspection at the manufacturing facility (Oncology) located at Sanand, Ahmedabad, Gujarat, India – 09.07.2025

Read More

Intimation under Regulation 30 – Incorporation of wholly-owned Subsidiary – Emcure Wellness Private Limited 04.07.2025

Read More

Intimation under Regulation 31A of the SEBI Listing Regulations – Submission of application for seeking re-classification from the ‘Promoter and Promoter Group’ category to ‘Public’ category

Read More

Intimation under Regulation 30 – Regulatory Order received on 24.06.2025

Read More

Intimation under Regulation 31A of the SEBI Listing Regulations – Outcome of the meeting of the Board of Directors considering requests for re-classification from the ‘Promoter and Promoter Group’ category to ‘Public’ category

Read More
Next